Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Methylphenidate/adverse effects"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Arquivos Brasileiros de Oftalmologia n.ahead 2022
Arquivos brasileiros de oftalmologia
Conselho Brasileiro de Oftalmologia (CBO)
instacron:CBO
Arquivos Brasileiros de Oftalmologia, Issue: ahead, Published: 23 SEP 2022
Arquivos brasileiros de oftalmologia
Conselho Brasileiro de Oftalmologia (CBO)
instacron:CBO
Arquivos Brasileiros de Oftalmologia, Issue: ahead, Published: 23 SEP 2022
Purpose: This study aimed to screen the ocular surface of children with attention deficit hyperactivity disorder and identify the adverse effects of methylphenidate related to dry eye disease. Methods: This cross-sectional study included children wit
Autor:
Anne Broe, Per Damkier
Publikováno v:
JAMA
Damkier, P & Broe, A 2020, ' First-Trimester Pregnancy Exposure to Modafinil and Risk of Congenital Malformations ', JAMA-Journal of the American Medical Association, vol. 323, no. 4, pp. 374-376 . https://doi.org/10.1001/jama.2019.20008
Damkier, P & Broe, A 2020, ' First-Trimester Pregnancy Exposure to Modafinil and Risk of Congenital Malformations ', JAMA-Journal of the American Medical Association, vol. 323, no. 4, pp. 374-376 . https://doi.org/10.1001/jama.2019.20008
This study uses pharmacoepidemiology data from Danish national health registries to examine the association between first-trimester exposure to modafinil and risk of major congenital malformations.
Autor:
Erica Ydedahl-Jensen, Trine Gerner, Helle B Krogh, Mathilde Holmskov, Erlend Faltinsen, Ole Jakob Storebø, Frederik L Magnusson, Christian Gluud, Adnan Todorovac, Erik Simonsen
Publikováno v:
Krogh, H B, Storebø, O J, Faltinsen, E, Todorovac, A, Ydedahl-Jensen, E, Magnusson, F L, Holmskov, M, Gerner, T, Gluud, C & Simonsen, E 2019, ' Methodological advantages and disadvantages of parallel and crossover randomised clinical trials on methylphenidate for attention deficit hyperactivity disorder : A systematic review and meta-analyses ', BMJ Open, vol. 9, no. 3, e026478 . https://doi.org/10.1136/bmjopen-2018-026478
BMJ Open
BMJ Open
ObjectiveTo assess the methodological advantages and disadvantages of parallel and crossover designs in randomised clinical trials on methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD).DesignSecondary an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::29b6cd1d29cd68a07aca0c0382c9ac47
https://findresearcher.sdu.dk:8443/ws/files/193060537/e026478.full.pdf
https://findresearcher.sdu.dk:8443/ws/files/193060537/e026478.full.pdf
Autor:
SS Nielsen, Nadia Pedersen, Frederik L Magnusson, Dorothy Gauci, M.L. Kielsholm, Camilla Groth, Trine Gerner, Erica Ramstad, Morris Zwi, Maria Skoog, Susanne Rosendal, Kirsten Buch Rasmussen, Donna Gillies, Christian Gluud, Richard Kirubakaran, Lise Aagaard, Helle B Krogh, Mathilde Holmskov, Ole Jakob Storebø, Sasja Jul Håkonsen, Erik Simonsen, Carlos Renato Moreira-Maia
Publikováno v:
Storebø, O J, Pedersen, N, Ramstad, E, Kielsholm, M L, Nielsen, S S, Krogh, H B, Moreira-Maia, C R, Magnusson, F L, Gerner, T, Skoog, M, Rosendal, S, Groth, C, Gillies, D, Buch Rasmussen, K, Gauci, D, Zwi, M, Kirubakaran, R, Håkonsen, S J, Aagaard, L, Simonsen, E & Gluud, C 2018, ' Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents-assessment of adverse events in non-randomised studies ', Cochrane Database of Systematic Reviews, no. 5, CD012069 . https://doi.org/10.1002/14651858.CD012069.pub2
Storebø, O J, Pedersen, N, Ramstad, E, Kielsholm, M L, Nielsen, S S, Krogh, H B, Moreira-Maia, C R, Magnusson, F L, Holmskov, M, Gerner, T, Skoog, M, Rosendal, S, Groth, C, Gillies, D, Buch Rasmussen, K, Gauci, D, Zwi, M, Kirubakaran, R, Håkonsen, S J, Aagaard, L, Simonsen, E & Gluud, C 2018, ' Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents-assessment of adverse events in non-randomised studies ', Cochrane Database of Systematic Reviews, vol. 5, CD012069 . https://doi.org/10.1002/14651858.CD012069.pub2
The Cochrane Library
Storebø, O J, Pedersen, N, Ramstad, E, Kielsholm, M L, Nielsen, S S, Krogh, H B, Moreira-Maia, C R, Magnusson, F L, Holmskov, M, Gerner, T, Skoog, M, Rosendal, S, Groth, C, Gillies, D, Buch Rasmussen, K, Gauci, D, Zwi, M, Kirubakaran, R, Håkonsen, S J, Aagaard, L, Simonsen, E & Gluud, C 2018, ' Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents-assessment of adverse events in non-randomised studies ', Cochrane Database of Systematic Reviews, vol. 5, CD012069 . https://doi.org/10.1002/14651858.CD012069.pub2
The Cochrane Library
Background: Attention deficit hyperactivity disorder (ADHD) is a common neurodevelopmental disorder in childhood. The psychostimulant methylphenidate is the most frequently used medication to treat it. Several studies have investigated the benefits o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5cb171078a21664271e7cb59dc42f613
https://vbn.aau.dk/da/publications/0d7b62a3-c3fe-4cbd-8770-c432a9edb2d2
https://vbn.aau.dk/da/publications/0d7b62a3-c3fe-4cbd-8770-c432a9edb2d2
Publikováno v:
Cochrane Database Syst Rev
Boesen, K, Paludan-Müller, A S, Gøtzsche, P C & Jørgensen, K J 2022, ' Extended-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults ', Cochrane Database of Systematic Reviews, vol. 2022, no. 2, CD012857 . https://doi.org/10.1002/14651858.CD012857.pub2
The Cochrane Library
Boesen, K, Paludan-Müller, A S, Gøtzsche, P C & Jørgensen, K J 2022, ' Extended-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults ', Cochrane Database of Systematic Reviews, vol. 2022, no. 2, CD012857 . https://doi.org/10.1002/14651858.CD012857.pub2
The Cochrane Library
Background: Attention deficit hyperactivity disorder (ADHD) is a psychiatric diagnosis increasingly used in adults. The recommended first-line pharmacological treatment is central nervous system (CNS) stimulants, such as methylphenidate, but uncertai
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e9b036c701843ed1e2eb29b5075e1fa3
https://europepmc.org/articles/PMC6486124/
https://europepmc.org/articles/PMC6486124/
Publikováno v:
Warrer, P, Aagaard, L & Holme Hansen, E 2014, ' Comparison of Pregnancy and Lactation Labeling for Attention-Deficit Hyperactivity Disorder Drugs Marketed in Australia, the USA, Denmark, and the UK ', Drug Safety, vol. 37, no. 10, pp. 805-813 . https://doi.org/10.1007/s40264-014-0215-2
Pregnancy and lactation labeling is presented in the officially recognized product information (PI) accompanying prescription drugs to ensure appropriate prescribing in pregnant and breastfeeding women. The aim of this study was to analyze pregnancy
Autor:
Ibrahim Yilmaz, Semih Akkaya, Mehmet Isyar, Seyit Ali Gümüştaş, Mahir Mahirogullari, Ahmet Guray Batmaz, Duygu Yasar Sirin, F. Gumustas
Publikováno v:
Humanexperimental toxicology. 36(9)
Purpose:Methylphenidate (MPH) derivative drugs are used because of psychostimulants effects on attention-deficit hyperactivity disorder in children and adults. As far as we know, toxic or anti-proliferative effects of MPH against cartilage tissue wer
Autor:
Lise Aagaard, Jesper Hallas, Anton Pottegård, Jon Trærup Andersen, Dorthe Dideriksen, Ellen Løkkegaard, Per Damkier
Publikováno v:
Pottegård, A, Hallas, J, Andersen, J T T, Løkkegaard, E, Dideriksen, D, Aagaard, L & Damkier, P 2014, ' First trimester exposure to methylphenidate : A population based cohort study ', Journal of Clinical Psychiatry, vol. 75, no. 1, pp. e88-e93 . https://doi.org/10.4088/JCP.13m08708
Objective: The use of methylphenidate to treat attention-deficit/ hyperactivity disorder has risen dramatically in Western countries, and it is increasingly used by adults, including women of childbearing age. Very little is known about potential haz
Publikováno v:
British Journal of Anaesthesia, vol. 100, no. 3, pp. 421-422
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b78295f67e25c8df8ba2323a9692118d
https://serval.unil.ch/resource/serval:BIB_4912887F9B04.P001/REF.pdf
https://serval.unil.ch/resource/serval:BIB_4912887F9B04.P001/REF.pdf